Original Research
Accepted on 06 Feb 2026
MiR-34a deficiency enhances nucleic acid sensing and type I IFN signaling in a mouse model of Alzheimer's disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Type at least 3 characters
1,504 articles
articles
Original Research
Accepted on 06 Feb 2026
Deep Gray Matter Atrophy Mediates the Associations Between Glymphatic Dysfunction and Clinical Disability in Relapsing-Remitting Multiple Sclerosis: A Neuroimaging Subgroup Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Accepted on 04 Feb 2026
Mitochondrial Transplantation Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Th17/Treg Balance and Restoring Metabolic Homeostasis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 221 views
Original Research
Accepted on 04 Feb 2026
Dysbiosis of intestinal microbiota in patients with neuromyelitis optica spectrum disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Review
Accepted on 04 Feb 2026
TREM2 and Microglial Immunity in Alzheimer's Disease: Mechanisms, Genetics, and Therapeutic Opportunities
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Accepted on 04 Feb 2026
Dysregulated NK cell gene expression defines the enduring symptoms of long COVID-19
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Published on 04 Feb 2026
Prognostic factors and a preliminary prognostic model in anti-GAD antibody-associated epilepsy
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1738062
- 508 views
Original Research
Accepted on 03 Feb 2026
Immune correlates underlying Small Fiber Neuropathy presenting as Vaccine-associated Post-Acute SARS-Coronavirus Syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 300 views
Original Research
Accepted on 02 Feb 2026
Targeting the Oxidative Stress-Neuroinflammation Axis: The Mechanism of Arctigenin's Broad-Spectrum Analgesia with Limited Side Effects
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Original Research
Published on 02 Feb 2026
Lupeol restores dopaminergic function by suppressing glial activation in a Parkinson’s disease mouse model
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1708581
- 686 views
Original Research
Published on 02 Feb 2026
Impact of preanalytical factors on blood CHI3L1 levels
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1720914
- 520 views
Original Research
Accepted on 31 Jan 2026
Kappa Free Light Chain index in CSF diagnostics: The impact of different Immunoglobulin Isotypes
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 192 views
Original Research
Accepted on 28 Jan 2026
A real-world study of ublituximab based on the WHO-VigiAccess and U.S. Food and Drug Administration's adverse event reporting system databases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 231 views
Original Research
Published on 28 Jan 2026
Safety and efficacy of B-cell therapy in older people with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1699550
- 825 views
Original Research
Accepted on 27 Jan 2026
Identification of plasma inflammatory biomarkers for Alzheimer's disease reveals IFN-γ as a regulator of ACSL1-mediated microglia phenotype
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 365 views
Review
Published on 27 Jan 2026
Immune crosstalk in Alzheimer’s and Parkinson’s disease: insights from Drosophila models into the brain–peripheral immune axis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1725046
- 525 views
Original Research
Published on 27 Jan 2026
CyTOF profiling identifies location-specific peripheral immune checkpoint and immune cell subset in mild ischemic stroke
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1739324
- 648 views
Review
Published on 27 Jan 2026
Nociplastic pain: the prominent role of non-neuronal cells in central and peripheral sensitization
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1677310
- 417 views
Review
Published on 26 Jan 2026
Deep cervical lymph node analysis in central nervous system inflammatory disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1747114
- 1,217 views
Editorial
Published on 22 Jan 2026
Editorial: The role of inflammasome in neuroinflammation and neurodegeneration
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1768702
- 700 views
Systematic Review
Published on 21 Jan 2026
Mapping the immune and epigenetic landscape of medication-overuse headache (MOH): a systematic review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2026.1756442
- 635 views
Original Research
Accepted on 19 Jan 2026
Telitacicept for Refractory AChR-Positive Generalized Myasthenia Gravis: A Retrospective Real-World Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 176 views
Brief Research Report
Published on 15 Jan 2026
Macrophage-targeted PEGylated liposomes ameliorate experimental autoimmune encephalomyelitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1657131
- 832 views
Original Research
Published on 14 Jan 2026
Disproportionality analysis of satralizumab in FDA adverse event reporting system and Japanese adverse drug event report: a pharmacovigilance study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1647306
- 862 views